Clinical Protocol SeCore, uTYPE and 3500 Dx System
NCT01285427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2014-04-17
Summary
The purpose of this study is to compare the Invitrogen SeCore(R) sequencing system and uTYPE(R) interpretation software to the predicate device Invitrogen SSP UniTray(R) with UniMatch(R) interpretation software and show 95% concordance with 90% confidence.
Conditions
- Human Leukocyte Antigens (HLA)
Sponsors & Collaborators
-
Life Technologies Corporation
lead INDUSTRY
Principal Investigators
-
Deanna Vella · Life Technologies
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
More Related Trials
-
CareSuperb COVID-19 Antigen Test Usability
NCT05629455 ·Status: COMPLETED ·Phase: NA
-
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
NCT06311435 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Aurora Xi New Nomogram Software 2.0
NCT06122935 ·Status: COMPLETED ·Phase: NA
-
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
NCT04368897 ·Status: WITHDRAWN
-
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
NCT04597047 ·Status: UNKNOWN ·Phase: NA
-
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
NCT01904188 ·Status: RECRUITING
-
Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)
NCT05403346 ·Status: TERMINATED
-
QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study
NCT05305534 ·Status: COMPLETED
-
Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)
NCT04750629 ·Status: COMPLETED
-
Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US
NCT04010695 ·Status: COMPLETED ·Phase: NA
-
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross
NCT01656174 ·Status: COMPLETED
-
Refractix DSP and TS Meter-DSP Measurement Comparison
NCT05717036 ·Status: UNKNOWN
-
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Healthy Blood Donors
NCT01277549 ·Status: COMPLETED
-
Micro-hematology Analyzer for Viral/Bacterial Description
NCT05090319 ·Status: UNKNOWN
-
Evaluation of MiSeq for Microbial Identification in Specimens
NCT02578875 ·Status: COMPLETED
-
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood
NCT04699903 ·Status: COMPLETED
-
A Normal Donor Sample Collection Study in Healthy Adults
NCT01318863 ·Status: COMPLETED
-
Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients
NCT06824402 ·Status: RECRUITING ·Phase: NA
-
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
NCT00520273 ·Status: COMPLETED ·Phase: NA
-
Spartan FRX Project Reproducibility Study
NCT01676298 ·Status: COMPLETED
-
Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting
NCT02176239 ·Status: COMPLETED
-
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS
NCT01702272 ·Status: COMPLETED
-
Optimization of Biotinylation Protocol for Studies of Red Blood Cell Survival and Function After Transfusion
NCT06788080 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
NCT05669261 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study of CT 5400 RT for System Validation
NCT06466577 ·Status: COMPLETED ·Phase: NA